|
|
1 | (6) |
|
1.1 Research Problem and Relevance |
|
|
1 | (1) |
|
1.2 Research Objectives and Scope |
|
|
2 | (1) |
|
1.3 Structure of the Book |
|
|
3 | (4) |
|
|
4 | (3) |
|
2 Bottom of the Pyramid Concept: Taking Stock |
|
|
7 | (20) |
|
|
7 | (1) |
|
2.2 Characteristics of the BOP Market |
|
|
8 | (3) |
|
2.3 Business Strategies at the BOP |
|
|
11 | (6) |
|
2.3.1 Challenges in Doing Business at the BOP |
|
|
11 | (2) |
|
|
13 | (3) |
|
2.3.3 Implications for the Firm |
|
|
16 | (1) |
|
2.4 Criticism of the BOP Approach |
|
|
17 | (3) |
|
2.4.1 Overestimation of Market Size |
|
|
18 | (1) |
|
|
18 | (1) |
|
2.4.3 Undermining the State's Role in Development and Other Alternatives to Capitalism |
|
|
19 | (1) |
|
2.4.4 Inability of MNCs to Address the BOP |
|
|
20 | (1) |
|
2.5 Current State of BOP Scholarship |
|
|
20 | (1) |
|
2.5.1 Evolution of the BOP Approach |
|
|
20 | (1) |
|
2.5.2 BOP Approach and Other Tangential Areas |
|
|
21 | (1) |
|
2.6 Why It Is Interesting and Imperative to Conduct BOP Research |
|
|
21 | (6) |
|
|
22 | (5) |
|
3 Disruptive Innovations Theory |
|
|
27 | (12) |
|
|
27 | (1) |
|
3.2 Disruptive Innovation Theory |
|
|
27 | (6) |
|
|
27 | (2) |
|
3.2.2 Extensions of the Disruptive Innovation Theory |
|
|
29 | (3) |
|
3.2.3 Disruptive Innovation in the Context of Technological Discontinuities |
|
|
32 | (1) |
|
3.2.4 Critique of Disruptive Innovation Theory |
|
|
33 | (1) |
|
3.3 Challenges in Commercializing Disruptive Innovations |
|
|
33 | (2) |
|
3.3.1 Resource Allocation Processes |
|
|
35 | (1) |
|
3.3.2 Inadequate Market-Facing Organizational Competency |
|
|
35 | (1) |
|
3.4 Recommendation to Established Firms Seeking to Commercialize Disruptive Innovations |
|
|
35 | (1) |
|
|
36 | (3) |
|
|
36 | (3) |
|
4 Methodology and Research Process |
|
|
39 | (8) |
|
|
39 | (1) |
|
|
39 | (2) |
|
|
39 | (1) |
|
4.2.2 Rationale for Case Study Research |
|
|
40 | (1) |
|
|
41 | (3) |
|
4.3.1 Case Study Selection |
|
|
42 | (1) |
|
|
43 | (1) |
|
|
43 | (1) |
|
4.4 Quality and Reliability |
|
|
44 | (3) |
|
|
45 | (2) |
|
5 Study Is The Bottom of the Pyramid Market as a Source for Disruptive Innovations |
|
|
47 | (28) |
|
5.1 Introduction and Research Question |
|
|
47 | (2) |
|
|
47 | (1) |
|
5.1.2 Research Question and Methodology |
|
|
48 | (1) |
|
5.2 Embedding the BOP Phenomenon in Theory |
|
|
49 | (4) |
|
5.2.1 Linking Disruptive Innovation Theory and BOP Markets |
|
|
49 | (1) |
|
5.2.2 How Frugal Innovations, Inclusive Innovations, Reverse Innovations, Gandhian Innovations and Disruptive Innovations are Interrelated |
|
|
50 | (3) |
|
|
53 | (7) |
|
5.3.1 Healthcare Challenges in India |
|
|
53 | (1) |
|
5.3.2 Case Studies: Aravind Eye Care System and Narayana Hrudayalaya Hospitals |
|
|
54 | (6) |
|
|
60 | (10) |
|
5.4.1 How Are Low-cost Specialty Hospital Chains Potentially Disruptive? |
|
|
60 | (3) |
|
5.4.2 What are the Drivers of Their Innovations? |
|
|
63 | (3) |
|
5.4.3 Short Excursus: Reflections on the Lead User Characteristics of AECS and NH |
|
|
66 | (2) |
|
5.4.4 Why is BOP an Appropriate Context for Disruptive Innovations? |
|
|
68 | (2) |
|
5.5 Managerial Implications and Discussion |
|
|
70 | (5) |
|
|
71 | (4) |
|
6 Study 2: Lessons from GE Healthcare: How Incumbents Can Systematically Create Disruptive Innovations |
|
|
75 | (30) |
|
|
75 | (1) |
|
|
76 | (2) |
|
6.3 Research Question and Methodology |
|
|
78 | (2) |
|
|
78 | (1) |
|
|
79 | (1) |
|
|
80 | (8) |
|
6.4.1 GE Healthcare Case Study |
|
|
80 | (5) |
|
6.4.2 Characteristics of the Value Segment Products |
|
|
85 | (3) |
|
|
88 | (12) |
|
6.5.1 Disruptive Potential of GE Healthcare's Value Segment Products |
|
|
88 | (2) |
|
6.5.2 Overcoming the Innovator's Dilemma |
|
|
90 | (5) |
|
6.5.3 Ambidexterity in Action at GE Healthcare |
|
|
95 | (3) |
|
6.5.4 Other Measures in Combating the Unfavorable Characteristics of Disruptive Innovations |
|
|
98 | (2) |
|
|
100 | (5) |
|
|
101 | (4) |
|
7 Study 3: Lessons from Tata: How Leadership Can Drive Disruptive Innovations |
|
|
105 | (26) |
|
|
105 | (2) |
|
7.2 Theoretical Foundations |
|
|
107 | (2) |
|
7.2.1 Leadership and Innovation |
|
|
107 | (2) |
|
7.2.2 Leadership and Ambidexterity |
|
|
109 | (1) |
|
7.3 Research Question and Methodology |
|
|
109 | (2) |
|
|
109 | (1) |
|
|
110 | (1) |
|
|
111 | (7) |
|
7.4.1 About Tata Group and Tata Chemicals |
|
|
111 | (1) |
|
|
112 | (6) |
|
|
118 | (9) |
|
7.5.1 Disruptive Potential of Tata Swach |
|
|
118 | (2) |
|
7.5.2 Role of Senior Leadership |
|
|
120 | (3) |
|
7.5.3 Differentiating and Integrating: A Process View of Ambidexterity at Tata |
|
|
123 | (4) |
|
|
127 | (4) |
|
|
127 | (4) |
|
8 Addendum: Linking Paradox Resolution and Disruptive Innovations for the Bottom of the Pyramid markets |
|
|
131 | (10) |
|
|
131 | (1) |
|
8.2 Theoretical Foundations: Theory of Paradox |
|
|
132 | (2) |
|
|
132 | (1) |
|
8.2.2 Pursuing Social and Financial Goals: A Performance Paradox |
|
|
133 | (1) |
|
|
134 | (2) |
|
|
136 | (1) |
|
|
137 | (4) |
|
|
138 | (3) |
|
9 Discussion of Findings and Conclusion |
|
|
141 | (16) |
|
9.1 Integration of Findings |
|
|
141 | (5) |
|
|
141 | (1) |
|
9.1.2 Organizational Conditions at Established Firms for Pursuing Disruptive Innovations |
|
|
142 | (4) |
|
9.2 Theoretical Contributions |
|
|
146 | (3) |
|
9.2.1 BOP as a Context for Disruptive Innovations |
|
|
146 | (1) |
|
9.2.2 Organizational Ambidexterity and Disruptive Innovation Theory |
|
|
146 | (2) |
|
9.2.3 Leadership and Disruptive Innovation Theory |
|
|
148 | (1) |
|
|
149 | (1) |
|
|
149 | (3) |
|
9.3.1 Managing Disruptive Innovations Within Established Firms |
|
|
150 | (1) |
|
9.3.2 Policy Implications for Healthcare Sector |
|
|
151 | (1) |
|
9.4 Limitations of the Research |
|
|
152 | (1) |
|
9.5 Future Research Agenda |
|
|
153 | (1) |
|
|
153 | (4) |
|
|
154 | (3) |
Appendix A Bottom of the Pyramid Innovations from India Mentioned in Studies |
|
157 | (2) |
|
Appendix B Interview List Study I |
|
159 | (2) |
Appendix C Interview List Study II |
|
161 | (2) |
Appendix D Interview List Study III and Addendum |
|
163 | (2) |
Appendix E Interview Guidelines |
|
165 | |